Basic Civil Engineering notes on Transportation Engineering & Modes of Transport
Guillain-Barre Syndrome Transmissional respiratory and gastrointestinal diagram .pdf
1. Guillain-Barre syndrome (GBS) is generally preceded by a respiratory or gastrointestinal infection, most commonly Campylobacter jejuni, but also Haemophilus influenzae,
Mycoplasma pneumoniae, CMV, HIV and EBV. Invading organisms are first detected by innate immune surveillance by phagocytes, such as dendritic cells, that engulf
pathogenic organisms by phagocytosis. The organisms are degraded in the lysosome and protein-derived peptide antigens are displayed on the cell surface in association
with HLA class II receptors. Activated dendritic cells then migrate to the T cell zone of secondary lymphoid organs, such as lymph nodes, for antigen presentation to T cells.
Campylobacter
jejuni
Infection
HLA II
Respiratory or gastrointestinal infection eg. Campylobacter jejuni.
Dendritic
cell
Bacterial
peptide
antigen
Lysosome
Activated
dendritic
cell
Lipo-oligosaccharide
antigen
2. Activated dendritic cells present protein-derived peptide antigens to CD4+ helper T cells in the T cell zone of secondary lymphoid organs, such as lymph nodes. Recognition
of peptide antigens by the T cell receptor (TCR) activates CD4+ T cells and induces cell proliferation which generates antigen-specific effector and memory T cells. Although
T-independent mechanisms for activating B cells are known, interaction with helper T cells is usually needed to allow B cells to differentiate into plasma cells and to switch
from IgM to other antibody isotypes, such as IgG, as well as to induce affinity maturation of antibodies and memory cell differentiation. In GBS, cross-reactive antibodies are
class-switched suggesting a role for helper T cells.
Naive
CD4+
Helper
T Lymphocyte
CD4
TCR
Antigen-specific CD4+ helper T lymphocyte activation.
Activated
CD4+
Helper
T Lymphocyte
TCR
CD4
HLA II
Bacterial
peptide
antigen
Secondary
lymphoid
organ
T cell
zone
Activated
dendritic
cell
3. In GBS, it is thought that antibodies initially directed towards lipo-oligosaccharide antigens later cross-react with similar epitopes (molecular mimicry), such as gangliosides
found on neurons or myelin. These antibodies are produced by B cells primed and activated in the secondary lymphoid organs where lipo-oligosaccharide antigens are
displayed on the surface of follicular dendritic cells. Naive B cells expressing B cell receptors (BCR) that recognise these antigens induce endocytosis of the antigen-receptor
complex. Although the antigen targeted by the antibody is not a protein, it is likely that pathogen-derived proteins are involved in B cell activation since recruitment of T cell
help is needed to induce isotype-switched antibodies seen in GBS.
“Naive”
B Lymphocyte
Antigen-specific B lymphocyte priming
Lipo-oligosaccharide
antigen
B cell
receptor
(BCR)
HLA II
“Primed”
B Lymphocyte
Campylobacter
jejuni
Secondary
lymphoid
organ
B cell
zone
Follicular
dendritic
cell
Germinal
centre
?
Unknown
bacterial
peptide
epitope
4. Primed B cells display peptide antigens bound to HLA class II receptors and become activated by previously activated CD4+ helper T cells that recognise specific peptide
antigen via the TCR. The BCR is targeted to lipo-oligosaccharide antigens which do not bind to HLA class II receptors, therefore it is likely that a peptide antigen, which is
unknown in GBS, is presented to T cells in order activate B cells and permit isotype switching. Although T-independent mechanisms for producing IgG2 antibodies in response
to polysaccharide antigens are known, in GBS, cross-reactive antibodies are of the IgG1 and IgG3 subclass which are T-dependent, potent activators of the classical
complement cascade and bind strongly to Fc receptors on phagocytes, such as macrophages.
Antigen-specific B lymphocyte activation
Plasma
B cell Isotype
switched
IgG1 or IgG3
Secondary
lymphoid
organ
T cell
zone
Activated
CD4+
Helper
T Lymphocyte
Activated
B Lymphocyte
CD4
HLA II
?
Unknown
bacterial
peptide
antigen
TCR
5. Clearance of invading organisms is mediated by soluble antibodies of the IgM and IgG class that bind to the surface of the pathogen and tag them for destruction by effector
mechanisms of the innate immune system. These include classical complement activation (IgG and IgM) and formation of the membrane attack complex, antibody-dependent
cell cytotoxicity (ADCC) mediated by Fc receptors on natural killer cells (IgG) and receptor-mediated phagocytosis via opsonisation of the pathogen with IgG or complement
C3b proteins, mediated by Fc receptors and complement receptors on phagocytes. In GBS, however, cross-reactive IgG antibodies will begin to trigger similar immune attacks
against peripheral nerves.
IgG
IgM
Campylobacter
jejuni
Antibody
dependent
cell
cytotoxicty
(ADCC)
Natural
killer
cell
Antibody-mediated destruction of the pathogen
Classical
complement
pathway
Receptor-
mediated
phagocytosis
C3b
Anti-
lipo-oligosaccharide
antibodies
Macrophage
Complement
receptor
Fc
receptor
C1
6. The most common subtype of GBS is demyelination associated with infiltration of macrophages and CD4+ helper T cells into peripheral nerve tissue (usually sensory or
motor neurons). It is thought that anti-myelin IgG antibodies mediate destruction of myelin via activation of the classical complement cascade and formation of the membrane
attack complex as well as activation of macrophages expressing Fc receptors and complement receptors that faciliate stripping of myelin. Further enhancement of macrophage
activity may be provided by infiltration of activated CD4+ helper T cells that secrete pro-inflammatory cytokines, such as IFN-γ and TNF-α.
Muscle
fibres
Neuron
Demyelination of nerve cells.
Myelin
antigen
Myelin
sheath
C1
C3b
CD4+
helper
T lymphocyte
Motor-
nerve
end-plate
terminal
Membrane
attack
complex
IFN-γ
TNF-α.
anti-
myelin
IgG
Blood-nerve
barrier
C5b-9
Macrophage
Fc
receptor
Complement
receptor
Receptor-
mediated
phagocytosis
7. A less common subtype of GBS involves immunological damage to the axon or motor-nerve end-plate terminals and is mediated by anti-ganglioside IgG antibodies. The
symptoms and severity depend on the type of ganglioside targeted since the membrane distribution of these molecules on nerve cells varies. Similar so demyelinating GBS,
nerve damage is caused by activation of the classical complement cascade and formation of the membrane attack complex or by infiltration of macrophages expressing Fc
receptors for IgG or complement receptors for complement C3b that initiate destructive phagocytic processes.
Neuron
Axonal or end-plate terminal damage.
Ganglioside
Myelin
sheath
C1
C3b
Nerve
axon
Muscle
fibres
Membrane
attack
complex
Motor-
nerve
end-plate
terminal
anti-
ganglioside
IgG
Blood-nerve
barrier
C5b-9
Macrophage
Fc
receptor
Complement
receptor
Receptor-
mediated
phagocytosis